Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study

PURPOSE: To compare the effectiveness of bevacizumab and ranibizumab in the treatment of exudative age-related macular degeneration (AMD). DESIGN: Multicentre, randomized, controlled, double-masked clinical trial in 327 patients. The non-inferiority margin was 4 letters. PATIENTS: Patients ≥ 60 year...

Descripción completa

Detalles Bibliográficos
Autores principales: Schauwvlieghe, A. M. E., Dijkman, G., Hooymans, J. M., Verbraak, F. D., Hoyng, C. B., Dijkgraaf, M. G. W., Peto, T., Vingerling, J. R., Schlingemann, R. O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874598/
https://www.ncbi.nlm.nih.gov/pubmed/27203434
http://dx.doi.org/10.1371/journal.pone.0153052

Ejemplares similares

Ejemplares similares